Showing results (121-130 of 250) with videos related to

Sort By:
Pageof 25
Anticancer Research|August 21, 2003
Docetaxel and epirubicin supported by granulocyte colony-stimulating factor first-line in advanced breast cancerAristides Polyzos, Nicholas Tsavaris, Christos Kosmas, et al.
Plos One|July 21, 2015
Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma PatientsAhmad A Tarhini, Yan Lin, Haris Zahoor, et al.
Cancer Medicine|September 14, 2019
Endocrine-related adverse events associated with immune-checkpoint inhibitors in patients with melanomaEva Kassi, Anna Angelousi, Nikolaos Asonitis, et al.
Cancer Investigation|January 12, 2005
Vinorelbine in combination with interleukin-2 as second-line treatment in patients with metastatic melanoma. A phase II study of the Hellenic Cooperative Oncology GroupHelen Gogas, D Bafaloukos, G Aravantinos, et al.
Anticancer Research|July 28, 2004
Tolerability of adjuvant high-dose interferon alfa-2b: 1 month versus 1 year--a Hellenic Cooperative Oncology Group studyHelen Gogas, Dimitrios Bafaloukos, John Ioannovich, et al.
Clinical Drug Investigation|May 26, 2007
Weekly Gemcitabine plus Fluorouracil-Folinic Acid Given Weekly for Two Days in Patients with Advanced Pancreatic Cancer : A Phase II StudyAristides Polyzos, Nicholas Tsavaris, Christos Kosmas, et al.
Plos One|January 30, 2014
A new mathematical model for the interpretation of translational research evaluating six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferonPetr Pancoska, John M Kirkwood, Spyros Bouros, et al.
Melanoma Research|December 13, 2023
Real-world management practices and characteristics of patients with advanced melanoma initiated on immuno-oncology or targeted therapy in the first-line setting during the period 2015-2018 in Greece. The 'SUMMER' study: a retrospective multicenter chart review projectDimitrios Bafaloukos, Panagiotis Kouzis, Panagiotis Gouveris, et al.
Anticancer Research|November 11, 2006
Subsets of patients with advanced gastric cancer responding to second-line chemotherapy with docetaxel-cisplatinAristides Polyzos, Nikolas Tsavaris, Christos Kosmas, et al.
Anticancer Research|June 29, 2007
Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxelAristides Polyzos, Christos Kosmas, Nikolas Tsavaris, et al.
Pageof 25